Blog Post
FDA’s Bendeka decision reverses approvals of Treanda generics
21 February 2019
Yesterday, FDA released a letter stating how the agency intends to implement the scope of orphan drug exclusivity awarded to Eagle Pharmaceuticals’ Bendeka (bendamustine HCl) by the...
